Patents Examined by William Levicky
  • Patent number: 9452289
    Abstract: Retinal prostheses are configured to apply retinal stimulus signals based on retinal cell classification such as cell types or cell clusters identified based on retinal cell signals. Cell types are identified based on spontaneous or induced retinal electrical signals and analyzed based on temporal patterns of electrical activity, spatio-temporal voltage waveforms, and signal correlations that can be obtained from temporal spike patterns. Cell type indications are stored, and a signals are applied to the retina based on the stored cell type indications.
    Type: Grant
    Filed: March 19, 2012
    Date of Patent: September 27, 2016
    Assignee: Pixium Vision SA
    Inventors: Eduardo-Jose Chichilnisky, Lauren Jepson, Martin Greschner
  • Patent number: 9451888
    Abstract: An apparatus and method for determining stroke volume by bioimpedance from a person that includes two or more spaced apart alternating current flow electrodes positionable on a person's forearm, two or more spaced apart voltage sensing electrodes positionable on the person's forearm and between the alternating current flow electrodes, an alternating current source providing an alternating current to the current flow electrodes, a voltmeter configured to generate a voltage signal from a voltage sensed by the voltage sensing electrodes, and a processing unit configured to determine a stroke volume (SV) using the voltage signal and at least one of two equations that include, among other terms, the person's weight, a peak time rate of change of a transradioulnar impedance pulse variation (dZ/dtmax), a transradioulnar quasi-static base impedance (Z0), a systolic flow time (TSF), and a volume conductor (Vc).
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: September 27, 2016
    Assignee: CORDEUS, INC.
    Inventor: Donald P. Bernstein
  • Patent number: 9446231
    Abstract: A neurostimulation system and method of providing therapy to a patient implanted with a plurality of electrodes using a plurality of electrical sources is provided. A source-electrode coupling configuration is determined from the electrical sources and electrodes. Electrical current is respectively conveyed between active ones of the plurality of electrical sources and active subsets of the plurality of electrodes in accordance with the determined source-electrode coupling configuration. The total number of the electrodes in the active electrode subsets is greater than the total number of the active electrical sources.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: September 20, 2016
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Rafael Carbunaru, Kristen Jaax, Andrew DiGiore
  • Patent number: 9445746
    Abstract: A system and method for catheter placement using ECG is provided. In certain embodiments, the system and method can generate a patient specific window for tracking a characteristic of an ECG waveform, such as the amplitude of a P-wave. The patient specific window can be utilized in a system and method for assisting in the placement of a catheter within a patient. In other embodiments, a tip location algorithm can be used with an anti-thrombogenic catheter and an intravascular electrode assembly for maintaining a high resolution intravascular signal in an ECG based catheter tip placement system.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 20, 2016
    Assignee: Angio Dynamics, Inc.
    Inventors: Lambertus Wilhelmus Johannes Elberse, Franciscus Ludovicus Maria Johannes Veldhuijzen
  • Patent number: 9439604
    Abstract: Systems, methods, and computer-readable media are provided for displaying on a user display device alarm-triggering events detected by the medical device based on the location of the user display device. The method comprises receiving alarm-triggering patient data from a medical device and determining the physical location of first and second user display devices. The method further comprises determining that the physical location of the first user display device is designated to have an alarm displayed, and that the physical location of the second user display device is not designated to have an alarm displayed. In response to these determinations, the content of the alarm is displayed on the first user display device.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: September 13, 2016
    Assignee: Cerner Innovation, Inc.
    Inventors: Christopher J. Heil, Jeremy A. Flores, Carol A. M. George
  • Patent number: 9440067
    Abstract: An electrode lead of a pacemaker includes a metal conductive core and a carbon nanotube film. The metal conductive core defines an extending direction. The carbon nanotube film wraps around the metal conductive core. The carbon nanotube film includes a plurality of carbon nanotubes extending substantially along the extending direction of the metal conductive core. A bared part is defined at one end of the electrode lead. A pacemaker using the above mentioned electrode lead is also disclosed.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: September 13, 2016
    Assignees: Tsinghua University, HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Yu-Quan Wang, Li Qian, Liang Liu, Chen Feng, Li Fan, Wen-Mei Zhao
  • Patent number: 9421374
    Abstract: An active implantable medical device for vagal stimulation with optimization of ventricular filling is disclosed. The device delivers stimulation pulses to the vagal nerve of the patient with an adjustable energy level. The device includes a hemodynamic sensor for measuring hemodynamic parameters of the patient's cardiac cycles and delivering a timing parameter representative of the ventricular filling time. The energy level of the vagal stimulation pulses is adjusted dynamically and repeatedly over several cardiac cycles. The energy level is varied during successive cardiac correlative changes in the filling time (FT1, FT2) are assessed, and the energy level is set to a level that maximizes the ventricular filling time.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: August 23, 2016
    Assignee: SORIN CRM SAS
    Inventor: Marcel Limousin
  • Patent number: 9421389
    Abstract: An instrument is described for assisting a rescuer in the proper administration of CPR. A sensor detects movement of the chest caused by ventilation. The sensor signals are processed to produce a control signal representative of the effectiveness of the ventilation. A lung icon is displayed in the outline shape of human lungs and the outline is displayed filled to a level which indicates the effectiveness of the ventilation.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: August 23, 2016
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventor: Curtis Freeman
  • Patent number: 9419372
    Abstract: A vented set screw is used to secure a connection between an implantable medical device and an implantable lead. The vented set screw includes one or more venting channels that allow liquid and/or gas to flow out of the implantable medical device when the implantable lead is being inserted into the implantable medical device and secured during an implantation procedure. This prevents pressure from building up at the connection, thereby ensuring proper performance of sensing and/or therapy delivery functions of the implantable medical device.
    Type: Grant
    Filed: October 25, 2010
    Date of Patent: August 16, 2016
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Lawrence D. Swanson, John M. Edgell, Nick A. Youker, Scott Dahl, Kevin P. Rodby
  • Patent number: 9381366
    Abstract: Per the disclosure subcutaneously implantable medical devices (IMDs) with rate responsive implantable pulse generator (IPG) capability that also include dual patient activity sensors are adaptively controlled. One of the activity sensors uses multiple electrodes adapted to acquire electrocardiographic signals and signals from non-cardiac muscle tissue (myopotentially-based signals). The signals from the electrode-based activity sensor are used to confirm and/or override the patient-activity sensor signals from the other non-myopotentially-based patient activity sensor. The electrodes are directly mechanically coupled to the housing of the IMD and electrically coupled to circuitry that filters, processes, and interprets both the patient activity sensor signals.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: July 5, 2016
    Assignee: Medtronic, Inc.
    Inventor: Christopher C. Stancer
  • Patent number: 9375574
    Abstract: A computer assisted programming method includes ramping up a stimulation current for a plurality of contacts on a lead. Patient feedback is received while the stimulation current is being ramped up. Patient feedback indicates that the patient is beginning to feel stimulation. Based on the patient feedback, amplitude of the stimulation current that resulted in the patient feedback is recorded, and contacts are divided into groups. The contacts are activated one group at a time to the recorded amplitude. For each activated group of contacts, whether the patient can feel stimulation is determined. Thereafter, the target group that caused the patient to feel stimulation is then sub-divided into sub-groups. This process repeats a plurality of cycles until one or more contacts that caused the patient to feel stimulation are identified. The recorded amplitude is assigned as a perception threshold for the identified one or more contacts.
    Type: Grant
    Filed: May 16, 2014
    Date of Patent: June 28, 2016
    Assignee: Nuvectra Corporation
    Inventors: Norbert Kaula, Yohannes Iyassu
  • Patent number: 9364660
    Abstract: A method for treating intractable pain via electrical stimulation of the spinal cord. Remote, non-contact stimulation of a selected region of spinal cord is achieved by placement of a transceiver patch directly on the surface of that region of spinal cord, with said patch optionally being inductively coupled to a transmitter patch of similar size on either the outer or inner wall of the dura surrounding that region of the spinal cord. By inductively exchanging electrical power and signals between said transmitter and transceiver patches, and by carrying out the necessary electronic and stimulus signal distribution functions on the transceiver patch, the targeted dorsal column axons can be stimulated without the unintended stray stimulation of nearby dorsal rootlets. Novel configurations of a pliable surface-sheath and clamp or dentate ligament attachment features which realize undamaging attachment of the patch to the spinal cord are described.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: June 14, 2016
    Assignees: University of Iowa Research Foundation, University of Virginia Patent Foundation
    Inventors: Matthew Howard, Timothy Brennan, Brian Dalm, Marcel Utz, George T. Gillies, Steven Scott, Randall S. Nelson, Robert Shurig
  • Patent number: 9364162
    Abstract: In general, this disclosure is directed to signal processing based methods to reject oversensing due to electromagnetic interference or other noise without compromising tachyarrhythmia detection sensitivity. A method comprises sensing a signal indicative of cardiac activity, detecting a cardiac event based on the signal, determining a count of fluctuations of the signal within a window between the detected cardiac event and a next cardiac event, and determining whether noise is present in the signal based on the count.
    Type: Grant
    Filed: May 3, 2010
    Date of Patent: June 14, 2016
    Assignee: Medtronic, Inc.
    Inventors: Jian Cao, Jeffrey M. Gillberg
  • Patent number: 9364390
    Abstract: An implantable electroacupuncture device (IEAD) treats obese conditions of a patient through application of stimulation pulses applied at acupoints SP4, LR8 or ST40, or their underlying nerves saphenous and peroneal. The IEAD comprises an implantable, coin-sized, self-contained, leadless electroacupuncture device having at least two electrodes attached to an outside surface of its housing. The device generates stimulation pulses in accordance with a specified stimulation regimen. Power management circuitry within the device allows a primary battery, having a high internal impedance, to be used to power the device. The stimulation regimen generates stimulation pulses during a stimulation session of duration T3 minutes applied every T4 minutes. The duty cycle, or ratio T3/T4, is very low, no greater than 0.05. The low duty cycle and careful power management allow the IEAD to perform its intended function for several years.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: June 14, 2016
    Assignee: Valencia Technologies Corporation
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy O. Greiner
  • Patent number: 9352134
    Abstract: A catheter has an inflatable assembly at its distal portion, including a containment chamber, an axial core and a plurality of longitudinally oriented partitions extending from the axial core to the wall of the chamber to divide the containment chamber into at least four inflatable sectors. Hydraulic valves are connected to respective sectors to enable selective inflation of the sectors by a fluid when the valves are connected to a source of the fluid, and at least one surface electrode is mounted on each of the sectors. When introduced into a heart chamber and diametrically opposed sectors are inflated the assembly is stably fixed against the walls of the heart chamber and readings can be obtained from the surface electrodes of the inflated sectors.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: May 31, 2016
    Assignee: BIOSENSE WEBSTER (ISRAEL) LTD.
    Inventors: Michael Levin, Yoav Lichtenstein, Avi Reuveni, Avigdor Rosenberg
  • Patent number: 9352161
    Abstract: Tissue stimulation systems generally include a pulse generating device for generating electrical stimulation pulses, at least one implanted electrode for delivering the electrical stimulation pulses generated by the pulse generating device, and a programmer capable of communicating with the pulse generating device. Stimulation pulses may be defined by several parameters, such as pulse width and amplitude. In methods of stimulating the tissue with the stimulation system, a user may adjust one of the parameters such as pulse width. The programmer may automatically adjust the pulse amplitude in response to the change in pulse width in order to maintain a substantially constant effect of the stimulation pulses.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: May 31, 2016
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: James R. Thacker, Harold Haut, Robert Nathan, David K. L. Peterson, Kerry Bradley
  • Patent number: 9345422
    Abstract: A method of locating a tip of a central venous catheter (“CVC”) having a distal and proximal pair of electrodes disposed within the superior vena cava, right atrium, and/or right ventricle. The method includes obtaining a distal and proximal electrical signal from the distal and proximal pair of electrodes and using those signals to generate a distal and proximal P wave, respectively. A deflection value is determined for each of the P waves. A ratio of the deflection values is then used to determine a location of the tip of the CVC. Optionally, the CVC may include a reference pair of electrodes disposed within the superior vena cava from which a reference deflection value may be obtained. A ratio of one of the other deflection values to the reference deflection value may be used to determine the location of the tip of the CVC.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: May 24, 2016
    Assignee: Bard Acess Systems, Inc.
    Inventor: Peter M. Rothenberg
  • Patent number: 9339335
    Abstract: Ultra-short pulsed laser radiation is applied to a patient's eye to create a row of bubbles oriented perpendicular to the axis of vision. The row of bubbles leads to a region of the eye to be ablated. In a second step, a femtosecond laser beam guided through the row of bubbles converts it to a channel perpendicular to the axis of vision. In a third step, a femtosecond laser beam is guided through the channel to ablate a portion of the eye. Using a femtosecond laser with intensity in the range of 1011-1015 W/cm2 for the second and third steps facilitates multi-photon ablation that is practically devoid of eye tissue heating. Creating bubbles in the first step increases the speed of channel creation and channel diameter uniformity, thereby increasing the precision of the subsequent multi-photon ablation.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: May 17, 2016
    Assignees: The Trustees of Princeton University
    Inventors: Nicholas S. Siegele, Li Deng, Szymon Suckewer
  • Patent number: 9339645
    Abstract: Stimulation of the facial nerve system (e.g., electrically, electromagnetically, etc.) in stroke patients will cause dilation of occluded arteries and dilation of surrounding arteries, allowing for blood flow to circumvent the obstruction and reach previously-deprived tissue. The device approaches the facial nerve and its branches in the vicinity of the ear. In use, the device can be inserted into the ear canal or placed in proximity to the ear in order to stimulate the facial nerve system without puncturing the tympanic membrane (e.g., using an electromagnetic field). The device can also be advanced into the middle ear through a puncture created in the tympanic membrane. Branches of the facial nerve in the middle ear can then be stimulated directly (e.g., by application of electrical current). The device can be used in the emergency treatment of acute stroke or as chronically-implanted/inserted variations for long-term maintenance of blood flow to the brain and stroke prevention.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: May 17, 2016
    Assignee: Nervive, Inc.
    Inventor: Mark Klingler Borsody
  • Patent number: 9333350
    Abstract: A therapy system for managing a psychiatric disorder of the patient may be controlled based on a patient mood state. Therapy may be delivered to a patient according to a therapy program, and a physiological parameter of the patient may be monitored during or after therapy delivery. The patient mood state may be determined based on the monitored physiological parameter, and the therapy delivery may be controlled based on the determined mood state. In some embodiments, the therapy delivery is stopped prior to determining the patient mood state and the therapy delivery is restarted upon detecting a negative mood state. In other embodiments, therapy delivery is delivered until a positive mood state is detected, at which point the therapy delivery may be stopped.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: May 10, 2016
    Assignee: Medtronic, Inc.
    Inventors: Mark T. Rise, Jonathon E. Giftakis, Paul H. Stypulkowski, Timothy J. Denison, Nathan A. Torgerson